Vitiligo, a common depigmenting skin disorder, has an estimated prevalence of 0.5–2% of
the population worldwide. The disease is characterized by the selective loss of melanocytes …

Vitiligo is the most common depigmenting disorder affecting 0.1%–2% of the population
worldwide. The characteristic white patches result from the selective loss of melanocytes …

Background: Vitiligo is an autoimmune disorder that causes patchy loss of skin
pigmentation. Up to 2.16% of pediatric patients may have vitiligo. This study estimated …

Background Autoimmune bullous diseases are rare and mostly occur in adults. Several
cases and small case series have been described in children, but no systematic study about …

Microneedling was initially introduced for skin rejuvenation; however, this minimally invasive
procedure is now being used for the treatment of multiple dermatological conditions. Recent …

Vitiligo is an acquired pigmentary disorder afflicting 0.5-2% of the world population for both
sexes and all races with a capricious and unpredictable course. It has a complex etiology …

BACKGROUND: Vitiligo is a common cutaneous disorder of the skin and hair caused by a
systemic depigmentation disorder that affects 1% of the population or less due to its onset in …

Vitiligo is an autoimmune progressive skin depigmenting disease. Tumor necrosis factor
alpha (TNF-α) is a pro-inflammatory cytokine and plays a crucial role in vitiligo development …

Vitiligo is a common acquired depigmenting skin disease characterized by a progressive
loss of functional melanocytes. It may appear from the first years of life to late adulthood …

Background: Vitiligo is a muco-cutaneous, autoimmune, localized, or disseminated disease,
which manifests through hypochromic or achromic macules, with loss in quality of life. The …